A Study of IL-7 to Restore Absolute Lymphocyte Counts in Sepsis Patients

NCT02640807 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

27

Enrollment

INDUSTRY

Sponsor class

Conditions

Severe Sepsis With Septic Shock

Interventions

DRUG: Interleukin-7
DRUG: Placebo

Sponsor

Revimmune

Collaborators

[object Object]
[object Object]